Thus, during disease progression most of the PSA produced by prostate tumor tissue would be released into the circulation in its soluble form, explaining the significant increase in srm-T-PSA, but not in ev-T-PSA concentrations. The gene discussed is KLK3; the disease is prostate neoplasm.